nach oben

Tumor Biology

Erschienen in:

02.12.2015 | Original Article

Prognostic significance of GPC5 expression in patients with prostate cancer

verfasst von: Changwen Zhang, Zhifei Liu, Li Wang, Baomin Qiao, E. Du, Li Li, Yong Xu, Zhihong Zhang

Erschienen in: Tumor Biology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to evaluate the protein level of glypican-5 (GPC5) and its relationship with clinicopathologic significance in prostate cancer. The protein level of GPC5 in 160 prostate cancer tissues and 60 adjacent normal samples was examined by immunohistochemistry analysis, and the results were correlated with clinicopathologic parameters. The level of GPC5 in prostate cancer tissues was markedly lower than that in normal cases, especially in high-risk prostate cancer. Additionally, the low expression of GPC5 was closely associated with increased serum prostate-specific antigen (PSA), higher Gleason scores, advanced tumor stage (T3), positive lymph node metastasis, and biochemical recurrence. Moreover, GPC5 low expression was an independent prognostic factor for overall survival of patients with prostate cancer. GPC5 protein expression showed a close correlation with the tumorigenesis and tumor progression of prostate cancer, and that might be applied as a novel biomarker for the prediction of diagnosis and prognosis of prostate cancer.

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMed

Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15:e484–92.CrossRefPubMedPubMedCentral

Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127:679–95.CrossRefPubMed

Klotz LPT. Low-risk and very-low-risk prostate cancer: is there a role for focal therapy in the era of active surveillance? Yes, the two approaches complement each other. Oncology (Williston Park). 2014;28:950–C953.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol. 2014;65:1046–55.CrossRefPubMedPubMedCentral

De Cat B, David G. Developmental roles of the glypicans. Semin Cell Dev Biol. 2001;12:117–25.CrossRefPubMed

Michael J, Neat NF, Jenner M, Goff L, Ashcroft K, Burford D, et al. Localisation of a novel region of recurrent amplification in follicular lymphoma to an ∼6.8 mb region of 13q32-33. Genes Chromosom Cancer. 2001;32:236–43.CrossRef

DA Reardon JJ, Sublett JE, Burger PC, Kun LK. Multiple genomic alterations including n-myc amplification in a primary large cell medulloblastoma. Pediatr Neurosurg. 2000;32:187–91.CrossRefPubMed

Williamson D, Selfe J, Gordon T, Lu Y-J, Pritchard-Jones K, Murai K, et al. Role for amplification and expression of glypican-5 in rhabdomyosarcoma. Cancer Res. 2007;67:57–65.CrossRefPubMed

10.

Zhang C, Zhang S, Zhang D, Zhang Z, Xu Y, Liu S. A lung cancer gene gpc5 could also be crucial in breast cancer. Mol Genet Metab. 2011;103:104–5.CrossRefPubMed

11.

Yang XZZ, Qiu M, Hu J, Fan X, Wang J, Xu L, et al. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer. Cancer Lett. 2013;341:265–73.CrossRefPubMed

12.

Zhao ZHC, Liu J, Wang C, Wang Y, Cheng L. Gpc5, a tumor suppressor, is regulated by mir-620 in lung adenocarcinoma. Mol Med Rep. 2014;9:2540–6.PubMed

13.

Li Y, Sheu C-C, Ye Y, de Andrade M, Wang L, Chang S-C, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010;11:321–30.CrossRefPubMedPubMedCentral

14.

Zhang C, Gao C, Xu Y, Zhang Z. Ctbp2 could promote prostate cancer cell proliferation through c-myc signaling. Gene. 2014;546:73–9.CrossRefPubMed

15.

Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RCN, Bangma CH, et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol. 2010;57:79–85.CrossRefPubMed

16.

Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384:2027–35.CrossRefPubMedPubMedCentral

17.

Song HH, Filmus J. The role of glypicans in mammalian development. Biochim Biophys Acta Gen Subj. 2002;1573:241–6.CrossRef

18.

DeBaun MR, Ess J, Saunders S. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition. Mol Genet Metab. 2001;72:279–86.CrossRefPubMed

19.

Xiang YYLV, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene. 2001;20:7408–12.CrossRefPubMed

20.

Kim HXG, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, et al. The heparan sulfate proteoglycan gpc3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol. 2003;29:694–701.CrossRefPubMed

Titel: Prognostic significance of GPC5 expression in patients with prostate cancer
verfasst von: Changwen Zhang
Zhifei Liu
Li Wang
Baomin Qiao
E. Du
Li Li
Yong Xu
Zhihong Zhang
Publikationsdatum: 02.12.2015
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 5/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-4499-3

Springer Medizin

Prognostic significance of GPC5 expression in patients with prostate cancer

Abstract

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis

MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF

Anticancer function of α-solanine in lung adenocarcinoma cells by inducing microRNA-138 expression

Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk

Epithelial–mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin

MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie